Phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme of the endogenous serine synthesis pathway, is highly expressed in colon cancer and significantly correlates with shorter OS in patients, serving as an independent adverse prognostic indicator [33]. Here, PHGDH is linked to colonic neoplasm.